BARUCH S BLUMBERG INSTITUTE

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2002

Legal Domicile

Principal Officer

LOUIS P KASSA III

Phone

2154894900

Tax Period

2024-07-01 to 2025-06-30

BARUCH S BLUMBERG INSTITUTE, founded in 2002, is a mid-sized nonprofit in the Medical Research sector that reported $14.5M in total revenue in fiscal year 2024. Revenue decreased 12% compared to the prior year.

Mission

THE MISSION OF THE BARUCH S. BLUMBERG INSTITUTE IS TO USE DISCOVERY SCIENCE TO FIND NEW THERAPIES FOR VIRAL HEPATITIS AND LIVER CANCER; TO ADVANCE ITS RESEARCH DISCOVERIES THROUGH TRADITIONAL SCHOLARSHIP AND EDUCATIONAL OPPORTUNITIES; TO NURTURE BIOTECHNOLOGY AND TO PROMOTE PUBLIC HEALTH OUTREACH PROGRAMS TO IMPROVE THE QUALITY OF LIFE FOR THOSE AFFECTED BY VIRAL HEPATITIS.

Program Service Accomplishments

Program 1

Expenses: $7,572,611 Revenue: $80,000

RESEARCH - TO DISCOVER AND/OR ASSIST IN THE DISCOVERY OF THERAPEUTICS, DIAGNOSTICS, AND PATHOGENESIS OF MEDICALLY IMPORTANT DISEASES IN GENERAL AND VIRAL HEPATITIS AND RELATED DISEASES IN PARTICULAR.

Program 2

Expenses: $1,673,670 Revenue: $1,951,637

B. LABS AT CIRA CENTER - BEGINNING IN JANUARY 2022, BSBI REPLICATED ITS SUCCESSFUL LIFE SCIENCES INCUBATOR MODEL BY PARTNERING WITH BRANDYWINE REALTY TRUST INCLUDING THE MANAGEMENT OF OPERATIONS...

B. LABS AT CIRA CENTER - BEGINNING IN JANUARY 2022, BSBI REPLICATED ITS SUCCESSFUL LIFE SCIENCES INCUBATOR MODEL BY PARTNERING WITH BRANDYWINE REALTY TRUST INCLUDING THE MANAGEMENT OF OPERATIONS, PROVIDING OF SERVICES TO AND RECRUITMENT OF COMPANIES FOR THE INCUBATOR.

Program 3

Expenses: $812,200 Revenue: $1,273,265

PUBLIC HEALTH OUTREACH AND TRAINING - TO PROMOTE AWARENESS OF LIVER DISEASES AND CHRONIC DISEASES; TO PROMOTE EDUCATION AND TRAINING IN THE AREA OF LIVER DISEASE ALONG WITH DISCOVERY RESEARCH AND...

PUBLIC HEALTH OUTREACH AND TRAINING - TO PROMOTE AWARENESS OF LIVER DISEASES AND CHRONIC DISEASES; TO PROMOTE EDUCATION AND TRAINING IN THE AREA OF LIVER DISEASE ALONG WITH DISCOVERY RESEARCH AND PUBLIC HEALTH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $10,565,075

Program Service Revenue $379,946

Investment Income $534,535

Other Revenue $3,060,960

TOTAL REVENUE $14,540,516

Expense Breakdown

Grants Paid $1,705,812

Salaries & Benefits $8,208,481

Fundraising Expenses $22,880

Program Expenses $10,243,394

Other Expenses $5,071,611

TOTAL EXPENSES $14,985,904

Year-over-Year Comparison

	2024	2023	Change
Revenue	$14,540,516	$16,543,762	-0.1%
Expenses	$14,985,904	$16,280,281	-0.1%
Net Income	$-445,388	$263,481	-2.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$961,324

Total Directors

$991,111

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELIZABETH SEEBER MBA CPA	TREASURER	0.50	Officer Director	$0	$0	$0
LOUIS P KASSA MPA	CEO/SECRETARY	15.00	Officer Director	$314,899	$40,371	$355,270
LOREN DANZIS ESQ	DIRECTOR	0.50	Director	$0	$0	$0
JOEL ROSEN ESQ	DIRECTOR	0.50	Director	$0	$0	$0
THOMAS SHENK PHD	DIRECTOR	0.50	Director	$0	$0	$0
JU-TAO GUO	PRESIDENT/SR VP FOR RESEARCH	40.00	Officer Director	$298,718	$37,671	$336,389
TIM BLOCK	DIRECTOR	0.50	Director	$35,898	$1,194	$37,092
CHARI COHEN	DIRECTOR (EFF 1/2025)	1.00	Director	$0	$42,163	$262,360
TONY FORD-HUTCHINSON	DIRECTOR	0.50	Director	$0	$0	$0
NIK HEBLE ESQ	DIRECTOR	0.50	Director	$0	$0	$0
RANDALL HYER MD PHD	PRESIDENT (THRU 7/2024)	16.00	Officer	$238,261	$31,404	$269,665
RICHARD PESTELL	DISTINGUISHED PROFESSOR	40.00	Highest	$272,651	$31,853	$304,504
JINHONG CHANG	VICE PRESIDENT, DRUG DEVELOPMENT	40.00	Highest	$277,614	$22,491	$300,105
MATTHEW BURKHARDT	DIRECTOR OF B. LABS	40.00	Highest	$182,599	$12,909	$195,508
YANMING DU	PROFESSOR OF MEDICINAL CHEMISTRY	40.00	Highest	$241,967	$30,175	$272,142
BOB CHRISTMAS	CHIEF OPERATING OFFICER	40.00	Highest	$236,510	$24,923	$261,433

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$14,540,516	$14,985,904	$10,531,733	$-445,388
2024	No data	No data	No data	No data
2023	$12,785,028	$13,256,616	$10,544,047	$-471,588
2022	$8,126,046	$8,509,549	$7,307,209	$-383,503
2021	$7,210,491	$7,397,172	$8,078,781	$-186,681
2020	$6,844,462	$7,716,962	$6,605,700	$-872,500
2019	$9,500,038	$7,635,772	$6,545,461	$1,864,266
2018	$7,591,446	$7,249,861	$6,171,218	$341,585